The Comparison of Stock Price Before and After Pandemic to Identify The Health of Sector Company

Abstract

At the beginning of the Covid-19 outbreak in Indonesia, almost all activities in this country were
disrupted and economic activity was no exception. Indonesia's current economic growth is down
2.07% in 2020 due to the Covid-19 pandemic which has caused it to be reduced to a low and middleincome country. Based on the gross domestic product (GDP), most sectors of the Indonesian economy
experienced a decline in growth in 2020. Only 5 economic sectors showed positive growth. The sector
with the largest positive growth was the health services sector and social activities, which amounted
to 11.60%. This growth affects the stock price of health sector companies. Grounded on the IDX
Industry category (IDXHEALTH) from 2018-2022, there was an increase of 41.28%. The Health
Sector which continues to grow is driven by the payment of Covid- 19 incentives. This study was
conducted to identify the Difference in Stock prices of Health Sector Companies before and after
Covid- 19 with the supposition that the Covid- 19 pandemic occurred in March 2020 by observing
stock price fluctuations two years before and after the Covid- 19 Pandemic. Based on the Paired
Sample T-test, the stock prices of 3 companies from 6 companies have significant differences in the
specified sample period, namely DVLA, PRDA, and MERK companies where the stock prices of
DVLA and PRDA have increased. In addition, PRDA's stock price has the largest stock price among
other health sector companies, meaning that PRDA companies have good performance.